Amneal Pharmaceuticals (AMRX) Shares Outstanding (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Shares Outstanding (Entity) of $319.0 million for Q1 2026, up 1.79% year-over-year from $313.4 million in Q1 2025, and up 1.41% quarter-over-quarter from $314.6 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Shares Outstanding (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $319.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1.79% year-over-year to $319.0 million; the TTM figure through Mar 2026 stood at $319.0 million (up 1.79% YoY), while the FY2025 annual figure was $314.6 million, up 1.51% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $319.0 million, up from $314.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $319.0 million in Q1 2026, with the low at $152.1 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $308.6 million (2024), against an average of $238.8 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) changed 0.0% in 2022, then jumped 101.29% in 2024.
- Amneal Pharmaceuticals' Shares Outstanding (Entity) stood at $152.1 million in 2022, then advanced by 15.79% to $176.1 million in 2023, then jumped by 75.93% to $309.9 million in 2024, then grew by 1.51% to $314.6 million in 2025, then increased by 1.41% to $319.0 million in 2026.
- Business Quant data shows AMRX's Shares Outstanding (Entity) at $319.0 million in Q1 2026, $314.6 million in Q4 2025, and $314.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | 319.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 319.20 Mn |
| Mar 31, 2026 | 316.02 Mn |
| Dec 31, 2025 | 313.37 Mn |
| Sep 30, 2025 | 314.17 Mn |
| Jun 30, 2025 | 313.74 Mn |
| Mar 31, 2025 | 311.05 Mn |
| Dec 31, 2024 | 308.98 Mn |
| Sep 30, 2024 | 309.65 Mn |
| Jun 30, 2024 | 309.12 Mn |
| Mar 31, 2024 | 307.28 Mn |
| Dec 31, 2023 | 176.14 Mn |
| Sep 30, 2023 | 154.22 Mn |
| Jun 30, 2023 | 153.74 Mn |
| Mar 31, 2023 | 152.11 Mn |
| Dec 31, 2022 | 150.94 Mn |
| Sep 30, 2022 | 151.39 Mn |
| Jun 30, 2022 | 150.99 Mn |
| Mar 31, 2022 | 149.89 Mn |
| Dec 31, 2021 | 148.92 Mn |
| Sep 30, 2021 | 149.29 Mn |